- Home
- POCI vs IGC Comparison
POCI vs IGC Comparison
Compare POCI & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- IGC
- Stock Information
- Founded
- POCI 1982
- IGC 2005
- Country
- POCI United States
- IGC United States
- Employees
- POCI N/A
- IGC N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- POCI Health Care
- IGC Health Care
- Exchange
- POCI Nasdaq
- IGC Nasdaq
- Market Cap
- POCI 33.4M
- IGC 33.8M
- IPO Year
- POCI N/A
- IGC N/A
- Fundamental
- Price
- POCI $4.59
- IGC $0.33
- Analyst Decision
- POCI
- IGC Strong Buy
- Analyst Count
- POCI 0
- IGC 2
- Target Price
- POCI N/A
- IGC $4.00
- AVG Volume (30 Days)
- POCI 30.6K
- IGC 641.0K
- Earning Date
- POCI 11-13-2025
- IGC 11-17-2025
- Dividend Yield
- POCI N/A
- IGC N/A
- EPS Growth
- POCI N/A
- IGC N/A
- EPS
- POCI N/A
- IGC N/A
- Revenue
- POCI $21,575,039.00
- IGC $1,106,000.00
- Revenue This Year
- POCI N/A
- IGC $3.54
- Revenue Next Year
- POCI N/A
- IGC $15.12
- P/E Ratio
- POCI N/A
- IGC N/A
- Revenue Growth
- POCI 13.67
- IGC N/A
- 52 Week Low
- POCI $3.77
- IGC $0.25
- 52 Week High
- POCI $5.48
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- POCI 54.21
- IGC 31.72
- Support Level
- POCI $4.26
- IGC $0.31
- Resistance Level
- POCI $4.69
- IGC $0.33
- Average True Range (ATR)
- POCI 0.33
- IGC 0.02
- MACD
- POCI 0.01
- IGC -0.00
- Stochastic Oscillator
- POCI 36.19
- IGC 15.30
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.